Novartis Commercial Paper Liability (Quarterly) Analysis

Novartis AG (NVS)

167.11 +2.41 (+1.46%) USD | NYSE | Feb 24, 16:00

168.17 +1.06 (+0.63%) After-Hours: 20:00

View Commercial Paper Liability (Quarterly) for NVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

Roche Holding AG	--
Amgen, Inc.	--
AstraZeneca PLC	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--